{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Tsalik EL"],"funding":["NIAID NIH HHS"],"pagination":["S41-S47"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5848376"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["64(suppl_1)"],"pubmed_abstract":["Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, w"],"journal":["Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"],"pubmed_title":["Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group."],"pmcid":["PMC5848376"],"funding_grant_id":["UM1 AI104681"],"pubmed_authors":["Banerjee R","Evans SR","Klausner JD","Patel R","Tsalik EL","Hanson KE","Lautenbach E","Petzold E","Kreiswirth BN","and the Diagnostics and Devices Committee","of the Antibacterial Resistance Leadership Group","Bonomo RA"],"additional_accession":[]},"is_claimable":false,"name":"Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group.","description":"Diagnostics are a cornerstone of the practice of infectious diseases. However, various limitations frequently lead to unmet clinical needs. In most other domains, diagnostics focus on narrowly defined questions, provide readily interpretable answers, and use true gold standards for development. In contrast, infectious diseases diagnostics must contend with scores of potential pathogens, dozens of clinical syndromes, emerging pathogens, rapid evolution of existing pathogens and their associated resistance mechanisms, and the absence of gold standards in many situations. In spite of these challenges, the importance and value of diagnostics cannot be underestimated. Therefore, the Antibacterial Resistance Leadership Group has identified diagnostics as 1 of 4 major areas of emphasis. Herein, w","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Mar","modification":"2025-04-19T00:28:55.152Z","creation":"2019-06-06T19:06:59Z"},"accession":"S-EPMC5848376","cross_references":{"pubmed":["28350903"],"doi":["10.1093/cid/ciw831"]}}